Wendell Su

General Partner

2022 - Current

https://angel.co/s/healthcare-syndicate/Oi5dd I am responsible for all activities within the syndicate, including deal sourcing, due diligence, investor relationship building, and content creation. We invest in founders with compassion for their customer’s pain, have unique insight into the healthcare problem, and have solutions that change the standard of care for the better. All in all, we believe these qualities allow our invested companies to attract the best talent as they scale, and build valuable companies that stand the test of time. Currently we are aiming for $100-200K checks, investing in early stage (Pre-Seed/Seed/Series A) digital health, medtech, and diagnostics companies. Join us on AngelList: https://angel.co/s/healthcare-syndicate/Oi5dd

Startup Mentor

2023

Advise early stage healthcare startups on fundraising, pitch deck, GTM strategy, etc.

Supercharger

2022

neonVest supercharges founders' networks by connecting early-stage founders to curated VCs and elite founder-operators for 1-on-1 coffee-chats. I help healthcare companies review pitch decks and their go to market strategies.

Angel Squad Member

2021

Investing with Hustle Fund at https://www.hustlefund.vc/angelsquad

Angel Investor

2020

• Screen healthcare-oriented startups for presentation at weekly meeting • Evaluate 2 startups weekly for potential investment

Board Member

2015

• Active participant in board discussion and setting strategic decisions • Directly worked with CEO on planning go to market strategy, and assisted in negotiations with key international distributors.

Board Member

2017 - 2020

CEO

2018 - 2020

• Successfully negotiated 2.4M USD product development partnership with WeHealth by Servier for heart attack detection system • Successfully negotiated pilot testing with leading US semiconductor company for evaluating Mobiosense technology in agricultural applications • Planned technology development roadmap and consistently executed on key deliverables on time • Directly interviewed, hired, and managed team of 3 scientists towards product development • Planned company budget and ensured financial health of company • Led discussions with key vendors and technology partners to secure essential technical services • Attended key industry trade shows (AHA, ESC) to promote initial product.

Director Of Business Development

2017 - 2018

• Successfully applied for and represented Mobiosense in international accelerators (Masschallenge, CDL, etc), frequently as only Asia-based company in cohort • Connected and maintained relationships with key advisors in semiconductor and healthcare industries to assist in semiconductor biosensor development and market validation • Planned go to market strategy around initial market approach, and generated associated financial projections.

Product Specialist

2015 - 2017

Lead Product Engineer

2013 - 2015

• Shortened multiday protocols with multiple assays into a complete, 24 hour diagnostic process • Trained coworkers and interns to independently run diagnostic protocols within device • Adapted macro scale IHC/ICC assay protocols for on chip use • Successfully cultured primary cells derived from biopsy tissues within microfluidic device • Interfaced with manufacturers to optimize design for prototyping and mass manufacturing • Tested various substrate material for biocompatibility with cell lines • Cultured and maintained mammalian cell lines • Drafted provisional patent for microfluidic device

Intern

2013 - 2013

• Collaborating with VP of product development to design microfluidics chip for prostate cancer diagnostics • Utilized flow simulation on Solidworks and COMSOL to analyze flow distribution and velocity profiles • Analyzed prostate cancer patient workflow to generate health economics model

Product Design/Development Team Member: Cough Analyzer

2012 - 2013

• Collaborated with 5 other engineering students to design cough analyzer for outpatient use • Followed FDA regulations on medical devices and Quality System Regulation • Drafted functional and performance requirements, pugh chart, risk assessment and other relevant documents